Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum

Glycobiology

Volumn 19, Issue 8, 2009, Pages 829-833

  Condac, Eduard ^a   Dale, George L ^b   Bender Neal, Diane ^c   Ferencz, Beatrix ^a   Towner, Rheal ^d   Hinsdale, Myron E ^a,b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Glycosyltransferase; Liver; Platelets; Proteoglycans; Serum

Indexed keywords

GLYCOSYLTRANSFERASE; RECOMBINANT ENZYME; THROMBIN; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE I; XYLOSYLTRANSFERASE II;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME KINETICS; ENZYME SUBSTRATE COMPLEX; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD PLATELETS; HUMANS; ISOENZYMES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; PENTOSYLTRANSFERASES; RECOMBINANT PROTEINS;

MUS;

EID: 67650330584     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp058     Document Type: Article

References (25)

1. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. 2000. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin. Blood. 95:1694-1702.
2. Ambrosius M, Kleesiek K, Götting C. 2008. The xylosyltransferase I gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels. Clin Biochem. 42:1-4.
3. Casanova JC, Kuhn J, Kleesiek K, Götting C. 2008. Heterologous expression and biochemical characterization of soluble human xylosyltransferase II. Biochem Biophys Res Commun. 365:678-684.
4. Casanova JC, Roch C, Kuhn J, Kleesiek K, Götting C. 2009. First in-gel detection and purification of human xylosyltransferase II. Biochem Biophys Res Commun. 379:243-248.
5. Condac E, Silasi-Mansat R, Kosanke S, Schoeb T, Towner R, Lupu F, Cummings RD, Hinsdale ME. 2007. Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA. 104:9416-9421.
6. Cuellar K, Chuong H, Hubbell SM, Hinsdale ME. 2007. Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II. J Biol Chem. 282:5195-5200.
7. Götting C, Hendig D, Adam A, Schön S, Schulz V, Szliska C, Kuhn J, Kleesiek K. 2005. Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J MolMed. 83:984-992.
8. Götting C, Kuhn J, Brinkmann T, Kleesiek K. 1998. Xylosylation of alternatively spliced isoforms of Alzheimer APP by xylosyltransferase. J Protein Chem. 17:295-302.
9. Götting C, Kuhn J, Kleesiek K. 2007. Human xylosyltransferases in health and disease. Cell Mol Life Sci. 64:1498-1517.
10. Götting C, Kuhn J, Kleesiek K. 2008. Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis. Diabetes Care. 31:2018-2019.
11. Götting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K. 2000. Molecular cloning and expression of human UDP-d-xylose: Proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol. 304:517-528.
12. Götting C, Sollberg S, Kuhn J, Weilke C, Huerkamp C, Brinkmann T, Krieg T, Kleesiek K. 1999. Serum xylosyltransferase: A new biochemical marker of the sclerotic process in systemic sclerosis. J Invest Dermatol. 112:919-924.
13. Harrison P, Cramer EM. 1993. Platelet alpha-granules. Blood Rev. 7:52-62.
14. Kleene R, Berger EG. 1993. The molecular and cell biology of glycosyltransferases. Biochim Biophys Acta. 1154:283-325.
15. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS. 1993. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53:1719-1723.
16. Paulson JC, Colley KJ. 1989. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem. 264:17615-17618.
17. Pfeil U, Wenzel KW. 2000. Purification and some properties of UDP-xylosyltransferase of rat ear cartilage. Glycobiology. 10:803-807.
18. Pönighaus C, Ambrosius M, Casanova JC, Prante C, Kuhn J, Esko JD, Kleesiek K, Götting C. 2007. Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J Biol Chem 282:5201-5206.
19. Raats CJ, Van Den Born J, Berden JH. 2000. Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int. 57:385-400.
20. Schön S, Prante C, Bahr C, Tarnow L, Kuhn J, Kleesiek K, Götting C. 2006. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes. Diabetes Care. 29:2295-2299.
21. Schön S, Schulz V, Prante C, Hendig D, Szliska C, Kuhn J, Kleesiek K, Götting C. 2006. Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. J Med Genet. 43:745-749.
22. Varki A, Esko J, Colley KJ. 2009. Cellular organization of glycosylation. In: Varki A et al., editors. Essentials of Glycobiology. Cold SpringHarbor (NY): Cold Spring Harbor Laboratory Press. p. xxix, 784.
23. Voglmeir J, Voglauer R, Wilson IB. 2007. XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity. J Biol Chem. 282:5984-5990.
24. Weilke C, Brinkmann T, Kleesiek K. 1997. Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin Chem. 43:45-51.
25. Wilson IB. 2004. The never-ending story of peptide O xylosyltransferase. Cell Mol Life Sci. 61:794-809.